Itopride in treatment of laryngopharyngeal symptoms of gastroesophageal reflux disease

Otolaryngol Pol. 2021 Dec 31;75(6):38-44. doi: 10.5604/01.3001.0015.5165.

Abstract

In everyday otolaryngological and gastroenterological practice, the diagnosis and treatment of extraesophageal forms of gastroesophageal reflux disease are often challenging. It is sometimes the case that treatment ordered by other specialists proves ineffective or even worsens the symptoms. There is no golden standard of diagnosis for otolaryngological forms of GERD, and currently used tools (gastroscopy, laryngoscopy, impedance and pH testing) have low sensitivity and specificity. After finishing a course of successful treatment, the patients often come back to our offices with the very same symptoms. In order to improve the efficacy of treatment, a prokinetic agent can be added to the standard proton pump inhibitor therapy.

Keywords: esophagolaryngeal reflux; gastroesophageal reflux disease; itopride.

MeSH terms

  • Benzamides
  • Benzyl Compounds
  • Gastroesophageal Reflux* / drug therapy
  • Humans
  • Laryngopharyngeal Reflux* / diagnosis
  • Laryngopharyngeal Reflux* / drug therapy
  • Laryngoscopy

Substances

  • Benzamides
  • Benzyl Compounds
  • itopride